Conditions: Advanced Non-squamous Non-small-cell Lung Cancer; Advanced Non-Small Cell Squamous Lung Cancer
Interventions: Drug: Initiation of nivolumab; Drug: Initiation of docetaxel
Sponsors: Brigham and Women’s Hospital; Food and Drug Administration (FDA)
Active, not **RECRUITING NOW**
Interventions: Drug: Initiation of nivolumab; Drug: Initiation of docetaxel
Sponsors: Brigham and Women’s Hospital; Food and Drug Administration (FDA)
Active, not **RECRUITING NOW**
Source: View full study details on ClinicalTrials.gov
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. By listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.
